Opendata, web and dolomites

Galastick

A medical device determining the daily amount of breast milk to improve neonatal nutrition andmothers’ psychophysics well-being.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Galastick project word cloud

Explore the words cloud of the Galastick project. It provides you a very rough idea of what is the project "Galastick" about.

successfully    medically    donor    prototype    assay    company    active    babies    mother    few    mothers    human    hospitals    occurs    simply    lack    newborn    galastick    nervousness    device    regulatory    analyte    plan    psychological    chain    lactation    frequent    engineer    people    milk    volunteer    reached    player    progressively    onset    proprietary    nutrition    stick    excess    inadequate    sme    midwiferies    biological    deep    supervised    pharma    starts    donate    works    feel    breastmilk    business    preliminary    tested    neonatal    absence    improves    crying    screened    disposable    commercialization    feeding    trl    detecting    colic    undermining    reveals    reduce    health    uses    diversity    lateral    medical    flow    industrialize    immunochromatographic    preterm    strategy    amount    depression    warning    market    certifications    samples    breastfeed    omini    integration    galascreen    daily    confidence    150    certified    wellness    assessing    breastfeeding    infants   

Project "Galastick" data sheet

The following table provides information about the project.

Coordinator
GALASCREEN SRLS 

Organization address
address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM
city: RENDE
postcode: 87036
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://talentlab.calabriainnova.it/galascreen/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GALASCREEN SRLS IT (RENDE) coordinator 50˙000.00
2    OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA IT (BUSSERO MILANO) participant 0.00

Map

 Project objective

'Biological diversity among people, reveals that not all mothers are the same. For some of them (not a few) it occurs that they are not able to successfully breastfeed their babies. Breastfeeding without 'feeding' can cause frequent crying and colic in the newborn and nervousness in mothers, lack of confidence in their abilities and depression. A mother starts to feel inadequate, undermining her psychological wellness. On the other hand, several mothers have breastmilk in excess and could donate it to preterm infants in midwiferies, thus promoting the babies' health and reduce hospitals' costs. Galascreen developed a proprietary disposable medical device, GalaStick, determining the lactation onset and the progressively increasing daily amount of breastmilk. The stick uses a lateral flow immunochromatographic assay that works simply detecting the presence (or absence) of a target analyte in the human milk sample. Such an easy to use stick not only improves the neonatal nutrition (warning if any feeding integration is needed), but also the psychological well-being of the mother. GalaStick has reached TRL 6 since a preliminary prototype has been tested with real human milk samples. More than 150 volunteer mothers and human milk donor mothers were successfully screened. Galascreen requires funding to engineer and industrialize the stick prototype and to get it medically certified as a medical device. Both key processes will be supervised and supported by the SME partner Omini Pharma. Phase 1 project will address a deep study on business development strategy and will define the value chain and the commercialization plan, together with assessing the regulatory procedures and certifications to be obtained by both the product and the company in order to be an active player on the medical market.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GALASTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GALASTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.6.;H2020-EU.2.3.1.)

Appytalent (2016)

Human Resource Management Tool Based on Emotional Intelligence

Read More  

PENSUMO (2017)

Savings Loyalty System Based on Micro-Contributions from Retailers

Read More  

P2Property (2017)

Peer to Peer Property

Read More